Tissue engineers have tried a number of schemes for building replacement organs out of patients’ own cells, but biophysi-cist Gabor Forgacs at the University of Missouri-Columbia has a new twist: let the cells assemble themselves. Forgacs and his team start with a printing device built by Sciperio, an R&D firm in Stillwater, OK, loaded with what he calls “bioink.” The bioink consists of spherical aggregates of many thousands of cells. The printer deposits the aggregates onto successive layers of biodegradable gel; by manipulating the composition of the gel, Forgacs can coax the aggregates to grow together to form complex structures while the gel degrades. Forgacs has already built three-dimensional blood-vessel-like modules and thinks a usable blood vessel will be ready in the near future. Another application Forgacs envisions is in cancer treatment. Doctors could take tumor cells from a patient, build an artificial replica of the tumor outside of his or her body, and see which drugs worked best on the replica before barraging the patient with different treatments.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.
Crypto is weathering a bitter storm. Some still hold on for dear life.
When a cryptocurrency’s value is theoretical, what happens if people quit believing?
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.